Click for best price
Lung Cancer Therapy Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Lung Cancer Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer Therapy. This report contains market size and forecasts of Lung Cancer Therapy in global, including the following market information:
The global Lung Cancer Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Radiation Therapy Segment to Reach $ Million by 2035, with a % CAGR in next six years.
The global key manufacturers of Lung Cancer Therapy include GlaxoSmithKline, Menarini, Pfizer, Roche, Merck, AstraZeneca, Sanofi-Aventis, Eli Lilly and Company and Abbott, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Lung Cancer Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lung Cancer Therapy Market, by Type, 2018-2023, 2024-2035 ($ millions)
Global Lung Cancer Therapy Market Segment Percentages, by Type, 2022 (%)
- Radiation Therapy
- Chemotherapy
- Targeted Therapies
- Immunotherapy
Global Lung Cancer Therapy Market, by Application, 2018-2023, 2024-2035 ($ millions)
Global Lung Cancer Therapy Market Segment Percentages, by Application, 2022 (%)
Global Lung Cancer Therapy Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions)
Global Lung Cancer Therapy Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Lung Cancer Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Lung Cancer Therapy revenues share in global market, 2022 (%)
key players include:
- GlaxoSmithKline
- Menarini
- Pfizer
- Roche
- Merck
- AstraZeneca
- Sanofi-Aventis
- Eli Lilly and Company
- Abbott
- Akebia Therapeutics
- Agennix AG
Outline of Major Chapters:
Chapter 1: Introduces the definition of Lung Cancer Therapy, market overview.
Chapter 2: Global Lung Cancer Therapy market size in revenue.
Chapter 3: Detailed analysis of Lung Cancer Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lung Cancer Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Lung Cancer Therapy Market, Global Outlook and Forecast 2023-2035 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Lung Cancer Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lung Cancer Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lung Cancer Therapy Overall Market Size
2.1 Global Lung Cancer Therapy Market Size: 2022 VS 2035
2.2 Global Lung Cancer Therapy Market Size, Prospects & Forecasts: 2018-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Lung Cancer Therapy Players in Global Market
3.2 Top Global Lung Cancer Therapy Companies Ranked by Revenue
3.3 Global Lung Cancer Therapy Revenue by Companies
3.4 Top 3 and Top 5 Lung Cancer Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Lung Cancer Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lung Cancer Therapy Players in Global Market
3.6.1 List of Global Tier 1 Lung Cancer Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Lung Cancer Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Lung Cancer Therapy Market Size Markets, 2022 & 2035
4.1.2 Radiation Therapy
4.1.3 Chemotherapy
4.1.4 Targeted Therapies
4.1.5 Immunotherapy
4.2 By Type - Global Lung Cancer Therapy Revenue & Forecasts
4.2.1 By Type - Global Lung Cancer Therapy Revenue, 2018-2023
4.2.2 By Type - Global Lung Cancer Therapy Revenue, 2024-2035
4.2.3 By Type - Global Lung Cancer Therapy Revenue Market Share, 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Lung Cancer Therapy Market Size, 2022 & 2035
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Other
5.2 By Application - Global Lung Cancer Therapy Revenue & Forecasts
5.2.1 By Application - Global Lung Cancer Therapy Revenue, 2018-2023
5.2.2 By Application - Global Lung Cancer Therapy Revenue, 2024-2035
5.2.3 By Application - Global Lung Cancer Therapy Revenue Market Share, 2018-2035
6 Sights by Region
6.1 By Region - Global Lung Cancer Therapy Market Size, 2022 & 2035
6.2 By Region - Global Lung Cancer Therapy Revenue & Forecasts
6.2.1 By Region - Global Lung Cancer Therapy Revenue, 2018-2023
6.2.2 By Region - Global Lung Cancer Therapy Revenue, 2024-2035
6.2.3 By Region - Global Lung Cancer Therapy Revenue Market Share, 2018-2035
6.3 North America
6.3.1 By Country - North America Lung Cancer Therapy Revenue, 2018-2035
6.3.2 US Lung Cancer Therapy Market Size, 2018-2035
6.3.3 Canada Lung Cancer Therapy Market Size, 2018-2035
6.3.4 Mexico Lung Cancer Therapy Market Size, 2018-2035
6.4 Europe
6.4.1 By Country - Europe Lung Cancer Therapy Revenue, 2018-2035
6.4.2 Germany Lung Cancer Therapy Market Size, 2018-2035
6.4.3 France Lung Cancer Therapy Market Size, 2018-2035
6.4.4 U.K. Lung Cancer Therapy Market Size, 2018-2035
6.4.5 Italy Lung Cancer Therapy Market Size, 2018-2035
6.4.6 Russia Lung Cancer Therapy Market Size, 2018-2035
6.4.7 Nordic Countries Lung Cancer Therapy Market Size, 2018-2035
6.4.8 Benelux Lung Cancer Therapy Market Size, 2018-2035
6.5 Asia
6.5.1 By Region - Asia Lung Cancer Therapy Revenue, 2018-2035
6.5.2 China Lung Cancer Therapy Market Size, 2018-2035
6.5.3 Japan Lung Cancer Therapy Market Size, 2018-2035
6.5.4 South Korea Lung Cancer Therapy Market Size, 2018-2035
6.5.5 Southeast Asia Lung Cancer Therapy Market Size, 2018-2035
6.5.6 India Lung Cancer Therapy Market Size, 2018-2035
6.6 South America
6.6.1 By Country - South America Lung Cancer Therapy Revenue, 2018-2035
6.6.2 Brazil Lung Cancer Therapy Market Size, 2018-2035
6.6.3 Argentina Lung Cancer Therapy Market Size, 2018-2035
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Lung Cancer Therapy Revenue, 2018-2035
6.7.2 Turkey Lung Cancer Therapy Market Size, 2018-2035
6.7.3 Israel Lung Cancer Therapy Market Size, 2018-2035
6.7.4 Saudi Arabia Lung Cancer Therapy Market Size, 2018-2035
6.7.5 UAE Lung Cancer Therapy Market Size, 2018-2035
7 Lung Cancer Therapy Companies Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Lung Cancer Therapy Major Product Offerings
7.1.4 GlaxoSmithKline Lung Cancer Therapy Revenue in Global Market (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Menarini
7.2.1 Menarini Company Summary
7.2.2 Menarini Business Overview
7.2.3 Menarini Lung Cancer Therapy Major Product Offerings
7.2.4 Menarini Lung Cancer Therapy Revenue in Global Market (2018-2023)
7.2.5 Menarini Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Lung Cancer Therapy Major Product Offerings
7.3.4 Pfizer Lung Cancer Therapy Revenue in Global Market (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Roche
7.4.1 Roche Company Summary
7.4.2 Roche Business Overview
7.4.3 Roche Lung Cancer Therapy Major Product Offerings
7.4.4 Roche Lung Cancer Therapy Revenue in Global Market (2018-2023)
7.4.5 Roche Key News & Latest Developments
7.5 Merck
7.5.1 Merck Company Summary
7.5.2 Merck Business Overview
7.5.3 Merck Lung Cancer Therapy Major Product Offerings
7.5.4 Merck Lung Cancer Therapy Revenue in Global Market (2018-2023)
7.5.5 Merck Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Lung Cancer Therapy Major Product Offerings
7.6.4 AstraZeneca Lung Cancer Therapy Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Sanofi-Aventis
7.7.1 Sanofi-Aventis Company Summary
7.7.2 Sanofi-Aventis Business Overview
7.7.3 Sanofi-Aventis Lung Cancer Therapy Major Product Offerings
7.7.4 Sanofi-Aventis Lung Cancer Therapy Revenue in Global Market (2018-2023)
7.7.5 Sanofi-Aventis Key News & Latest Developments
7.8 Eli Lilly and Company
7.8.1 Eli Lilly and Company Company Summary
7.8.2 Eli Lilly and Company Business Overview
7.8.3 Eli Lilly and Company Lung Cancer Therapy Major Product Offerings
7.8.4 Eli Lilly and Company Lung Cancer Therapy Revenue in Global Market (2018-2023)
7.8.5 Eli Lilly and Company Key News & Latest Developments
7.9 Abbott
7.9.1 Abbott Company Summary
7.9.2 Abbott Business Overview
7.9.3 Abbott Lung Cancer Therapy Major Product Offerings
7.9.4 Abbott Lung Cancer Therapy Revenue in Global Market (2018-2023)
7.9.5 Abbott Key News & Latest Developments
7.10 Akebia Therapeutics
7.10.1 Akebia Therapeutics Company Summary
7.10.2 Akebia Therapeutics Business Overview
7.10.3 Akebia Therapeutics Lung Cancer Therapy Major Product Offerings
7.10.4 Akebia Therapeutics Lung Cancer Therapy Revenue in Global Market (2018-2023)
7.10.5 Akebia Therapeutics Key News & Latest Developments
7.11 Agennix AG
7.11.1 Agennix AG Company Summary
7.11.2 Agennix AG Business Overview
7.11.3 Agennix AG Lung Cancer Therapy Major Product Offerings
7.11.4 Agennix AG Lung Cancer Therapy Revenue in Global Market (2018-2023)
7.11.5 Agennix AG Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Lung Cancer Therapy Market Opportunities & Trends in Global Market
Table 2. Lung Cancer Therapy Market Drivers in Global Market
Table 3. Lung Cancer Therapy Market Restraints in Global Market
Table 4. Key Players of Lung Cancer Therapy in Global Market
Table 5. Top Lung Cancer Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Lung Cancer Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Lung Cancer Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Lung Cancer Therapy Product Type
Table 9. List of Global Tier 1 Lung Cancer Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lung Cancer Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Lung Cancer Therapy Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Lung Cancer Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Lung Cancer Therapy Revenue in Global (US$, Mn), 2024-2035
Table 14. By Application ? Global Lung Cancer Therapy Revenue, (US$, Mn), 2022 & 2035
Table 15. By Application - Lung Cancer Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Lung Cancer Therapy Revenue in Global (US$, Mn), 2024-2035
Table 17. By Region ? Global Lung Cancer Therapy Revenue, (US$, Mn), 2022 & 2035
Table 18. By Region - Global Lung Cancer Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Lung Cancer Therapy Revenue (US$, Mn), 2024-2035
Table 20. By Country - North America Lung Cancer Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Lung Cancer Therapy Revenue, (US$, Mn), 2024-2035
Table 22. By Country - Europe Lung Cancer Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Lung Cancer Therapy Revenue, (US$, Mn), 2024-2035
Table 24. By Region - Asia Lung Cancer Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Lung Cancer Therapy Revenue, (US$, Mn), 2024-2035
Table 26. By Country - South America Lung Cancer Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Lung Cancer Therapy Revenue, (US$, Mn), 2024-2035
Table 28. By Country - Middle East & Africa Lung Cancer Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Lung Cancer Therapy Revenue, (US$, Mn), 2024-2035
Table 30. GlaxoSmithKline Company Summary
Table 31. GlaxoSmithKline Lung Cancer Therapy Product Offerings
Table 32. GlaxoSmithKline Lung Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. GlaxoSmithKline Key News & Latest Developments
Table 34. Menarini Company Summary
Table 35. Menarini Lung Cancer Therapy Product Offerings
Table 36. Menarini Lung Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Menarini Key News & Latest Developments
Table 38. Pfizer Company Summary
Table 39. Pfizer Lung Cancer Therapy Product Offerings
Table 40. Pfizer Lung Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Pfizer Key News & Latest Developments
Table 42. Roche Company Summary
Table 43. Roche Lung Cancer Therapy Product Offerings
Table 44. Roche Lung Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Roche Key News & Latest Developments
Table 46. Merck Company Summary
Table 47. Merck Lung Cancer Therapy Product Offerings
Table 48. Merck Lung Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Merck Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Lung Cancer Therapy Product Offerings
Table 52. AstraZeneca Lung Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Sanofi-Aventis Company Summary
Table 55. Sanofi-Aventis Lung Cancer Therapy Product Offerings
Table 56. Sanofi-Aventis Lung Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Sanofi-Aventis Key News & Latest Developments
Table 58. Eli Lilly and Company Company Summary
Table 59. Eli Lilly and Company Lung Cancer Therapy Product Offerings
Table 60. Eli Lilly and Company Lung Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Eli Lilly and Company Key News & Latest Developments
Table 62. Abbott Company Summary
Table 63. Abbott Lung Cancer Therapy Product Offerings
Table 64. Abbott Lung Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Abbott Key News & Latest Developments
Table 66. Akebia Therapeutics Company Summary
Table 67. Akebia Therapeutics Lung Cancer Therapy Product Offerings
Table 68. Akebia Therapeutics Lung Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Akebia Therapeutics Key News & Latest Developments
Table 70. Agennix AG Company Summary
Table 71. Agennix AG Lung Cancer Therapy Product Offerings
Table 72. Agennix AG Lung Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Agennix AG Key News & Latest Developments
List of Figures
Figure 1. Lung Cancer Therapy Segment by Type in 2022
Figure 2. Lung Cancer Therapy Segment by Application in 2022
Figure 3. Global Lung Cancer Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Lung Cancer Therapy Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Lung Cancer Therapy Revenue, 2018-2035 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lung Cancer Therapy Revenue in 2022
Figure 8. By Type - Global Lung Cancer Therapy Revenue Market Share, 2018-2035
Figure 9. By Application - Global Lung Cancer Therapy Revenue Market Share, 2018-2035
Figure 10. By Type - Global Lung Cancer Therapy Revenue, (US$, Mn), 2022 & 2035
Figure 11. By Type - Global Lung Cancer Therapy Revenue Market Share, 2018-2035
Figure 12. By Application - Global Lung Cancer Therapy Revenue, (US$, Mn), 2022 & 2035
Figure 13. By Application - Global Lung Cancer Therapy Revenue Market Share, 2018-2035
Figure 14. By Region - Global Lung Cancer Therapy Revenue Market Share, 2018-2035
Figure 15. By Country - North America Lung Cancer Therapy Revenue Market Share, 2018-2035
Figure 16. US Lung Cancer Therapy Revenue, (US$, Mn), 2018-2035
Figure 17. Canada Lung Cancer Therapy Revenue, (US$, Mn), 2018-2035
Figure 18. Mexico Lung Cancer Therapy Revenue, (US$, Mn), 2018-2035
Figure 19. By Country - Europe Lung Cancer Therapy Revenue Market Share, 2018-2035
Figure 20. Germany Lung Cancer Therapy Revenue, (US$, Mn), 2018-2035
Figure 21. France Lung Cancer Therapy Revenue, (US$, Mn), 2018-2035
Figure 22. U.K. Lung Cancer Therapy Revenue, (US$, Mn), 2018-2035
Figure 23. Italy Lung Cancer Therapy Revenue, (US$, Mn), 2018-2035
Figure 24. Russia Lung Cancer Therapy Revenue, (US$, Mn), 2018-2035
Figure 25. Nordic Countries Lung Cancer Therapy Revenue, (US$, Mn), 2018-2035
Figure 26. Benelux Lung Cancer Therapy Revenue, (US$, Mn), 2018-2035
Figure 27. By Region - Asia Lung Cancer Therapy Revenue Market Share, 2018-2035
Figure 28. China Lung Cancer Therapy Revenue, (US$, Mn), 2018-2035
Figure 29. Japan Lung Cancer Therapy Revenue, (US$, Mn), 2018-2035
Figure 30. South Korea Lung Cancer Therapy Revenue, (US$, Mn), 2018-2035
Figure 31. Southeast Asia Lung Cancer Therapy Revenue, (US$, Mn), 2018-2035
Figure 32. India Lung Cancer Therapy Revenue, (US$, Mn), 2018-2035
Figure 33. By Country - South America Lung Cancer Therapy Revenue Market Share, 2018-2035
Figure 34. Brazil Lung Cancer Therapy Revenue, (US$, Mn), 2018-2035
Figure 35. Argentina Lung Cancer Therapy Revenue, (US$, Mn), 2018-2035
Figure 36. By Country - Middle East & Africa Lung Cancer Therapy Revenue Market Share, 2018-2035
Figure 37. Turkey Lung Cancer Therapy Revenue, (US$, Mn), 2018-2035
Figure 38. Israel Lung Cancer Therapy Revenue, (US$, Mn), 2018-2035
Figure 39. Saudi Arabia Lung Cancer Therapy Revenue, (US$, Mn), 2018-2035
Figure 40. UAE Lung Cancer Therapy Revenue, (US$, Mn), 2018-2035
Figure 41. GlaxoSmithKline Lung Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Menarini Lung Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Pfizer Lung Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Roche Lung Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Merck Lung Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AstraZeneca Lung Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Sanofi-Aventis Lung Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Eli Lilly and Company Lung Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Abbott Lung Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Akebia Therapeutics Lung Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Agennix AG Lung Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
